English Polski
Vol 16, No 4 (2023)
Conference report / Report
Published online: 2024-02-09

open access

Page views 223
Article views/downloads 174
Get Citation

Connect on Social Media

Connect on Social Media

Wybrane zagadnienia dotyczące inaktywacji czynników chorobotwórczych w składnikach krwi w świetle doniesień prezentowanych na 33. Regionalnym Kongresie International Society of Blood Transfusion (ISBT) w Göteborgu, 17–21 czerwca 2023 roku

Paulina Goczyńska1, Joanna Lasocka1, Elżbieta Lachert1
Journal of Transfusion Medicine 2023;16(4):284-290.

Abstract

Not available

Article available in PDF format

View PDF (Polish) Download PDF file

References

  1. Seltsam A, Update on pathogen inactivation of whole blood, red blood cells, platelets and plasma, Vox Sang.2023, PA08-L01. .
  2. Richard P, Thibert J, Malard L et al. Implementation of 100% pathogen-reduced platelet concentrates in France: Impact on manufacturing and issuing of platelet concentrates as well as on the risk of transfusion-transmitted infections. Vox Sang., PA08-L02. .
  3. Hechler B, Brouard N, Rudwill F, Mouriaux C, Et al. In vitro biochemical and functional characteristics of stored (double-dose) buffy-coat platelet concentrates treated with amotosalen and a prototype UVA light-emitting diode iluminator, Vox Sang. 2023, P202. .
  4. Krath M, Nahata P, McCormack M, Johnson A, Et al. Amotosalen and UVA treatment of enterobacter soli, leclercia adecarboxylata and staphylococcus saoriohyticus from a contaminated apheresis platelet unit, Vox Sang. 2023, P203. .
  5. Nahata P, McCormack M, Johnson A, Stafford B, Et al., Inactivation of WHO reference bacterial strains in platelet and plasma coponents using Amotosalen/UVA treatment, Vox Sang. 2023, P209. .
  6. Auvinen M, Löf H, Knutson F, Pathogen reduced plasmas from maxi-pools combined with fast thawing for use in emergency situations, Vox Sang. 2023, P207. .
  7. Van Der Meer P, Groot S, Klei T, Improvment of platelet quality after pathogen inactivation, Vox Sang. 2023, P206. .
  8. Bubiński M, Gronowska A, Lasocka J, Lachert E, Evaluation of CD44, CD47 and annexin V expression in leuko-reduced packed RBCs stored in additive solution obtained from WB subjected to pathogen inactivation and separation, Vox Sang. 2023, P212. .
  9. Malvaux N, Defraigne F, Schuhmacher A, Initial experience of switching pathogen inactivation system with extended platelet shelf life, Vox Sang. 2023, P205. .
  10. Gravemann U, Sumian C, Schulze T, Virus inactivation of plasma by methylene blue/light treatment using a DEHP-free bag system, Vox Sang. 2023, P204. .
  11. Gravemann U, Sumian C, Schulze T, Bacteria elimination from plasma by methylene blue/light treatment using a DEHP-free bag system, Vox Sang. 2023, P208, DOU. .
  12. Handke W, Dresel S, Seltsam A, Implementation of a UVC-based pathogen reduction treatment for apheresis platelets at regional blood service in Germany, Vox Sang. 2023, P210. .
  13. Benjamin R J, Pitman J P, von Goetz M, Et al., A pilot study tracking pathogen reduced RBCs in vivo using Surface acridine and biotin flow cytometric markers, Vox Sang. 2023, P211. .